Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Conference Highlights ADA
Conference Highlights ADA
Once-Weekly GLP-1 Agonist Noninferior to Metformin in Treatment-Naïve Patients with Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Adding Saxagliptin to Metformin Improves Glycemic Control Over Uptitrating Metformin Dose
Wayne Kuznar
Read More
Conference Highlights ADA
Initiation of Therapy with a Sulfonylurea Increased Risk of Cardiovascular Events versus Metformin in Older Adults with Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Linagliptin as Effective as Glimepiride with Improved Safety Profile
Alice Goodman
Read More
Conference Highlights ADA
Diabetes Prevention with Metformin Is Cost-Saving for Persons at High Risk
Wayne Kuznar
Read More
Conference Highlights ADA
Nurse Educators as Part of Team Approach Improve Outcomes and Lower Costs Associated with Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Blood Glucose Testing a Significant Contributor to Pharmacy Costs in Patients Using Insulin
Wayne Kuznar
Read More
Perspectives
,
Conference Highlights ADA
ADA President’s Views on Clinical Management of Type 2 Diabetes
Alice Goodman
Read More
Conference Highlights ADA
Insulin Inappropriately Discontinued in Many Type 2 Diabetes Patients After Hospitalization
Wayne Kuznar
Read More
Conference Highlights ADA
Type 2 Diabetes Treatment in Patients with CKD Should Conform to NKF Guidelines for Better Outcomes, Lower Costs
Alice Goodman
Read More
1
2
3
Page 2 of 3
Results 11 - 20 of 22